BioCentury | Oct 7, 2020
Tools & Techniques

Doudna and Charpentier, CRISPR pioneers behind a spate of gene editing companies, awarded Nobel Prize

...approved until more than a decade later. Lauren Martz Max Planck Institute of Biochemistry University...
BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...predict chemotherapy response and survival in high-grade serous ovarian cancer (HGSOC) University of Chicago ; Max Planck Institute of Biochemistry...
BioCentury | Oct 25, 2018
Distillery Techniques

Biomarkers

...University of Chicago, Chicago, Ill. email: elengyel@uchicago.edu CONTACT: Matthias Mann, Max Planck Institute of Biochemistry, Martinsried, Germany email: mmann@biochem.mpg.de Mark Zipkin Max Planck Institute of Biochemistry University...
BioCentury | Dec 20, 2016
Distillery Techniques

Assays and screens

...M. et al. Nat. Commun. ; published online Nov. 21, 2016 doi:10.1038/ncomms13404 CONTACT: Matthias Mann, Max Planck Institute of Biochemistry...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...cells and elicit antimetastatic effects. To do this, Penninger teamed up with scientists from the Max Planck Institute of Biochemistry...
...in the paper, including LDC1267, is licensed to Qurient Co. Ltd. from LDC and the Max Planck Institute of Biochemistry...
...the Austrian Academy of Sciences , Vienna, Austria Lead Discovery Center GmbH , Dortmund, Germany Max Planck Institute of Biochemistry...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Cancer

...7(10); doi:10.1038/scibx.2014.281 Published online March 13, 2014 Patent filed by Lead Discovery Center GmbH and Max Planck Institute of Biochemistry...
BioCentury | Feb 13, 2014
Distillery Techniques

Technology: Disease models

...Heger, K. et al. PLoS Biol.; published online Jan. 14, 2014; doi:10.1371/journal.pbio.1001762 Contact: Marc Schmidt-Supprian, Max Planck Institute of Biochemistry...
BioCentury | Jan 16, 2014
Targets & Mechanisms

Putting a lid on cancer cell proteasomes

...SciBX . Baumeister is a professor at the Technical University Munich and director at the Max Planck Institute of Biochemistry...
...Mass. Howard Hughes Medical Institute , Pasadena, Calif. The Johns Hopkins University , Baltimore, Md. Max Planck Institute of Biochemistry...
BioCentury | Mar 5, 2009
Distillery Therapeutics

Indication: Hematology

...Moser, M. et al. Nat. Med.; published online Feb. 22, 2009; doi:10.1038/nm.1921 Contact: Reinhard Fässler, Max Planck Institute of Biochemistry...
BioCentury | Oct 30, 2008
Tools & Techniques

Expanding the kinase kingdom

...acute myelogenous leukemia (AML). Axel Ullrich, director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry...
...NASDAQ:GPCB), Munich, Germany Harvard Medical School , Boston, Mass. Kinaxo Biotechnologies GmbH , Martinsried, Germany Max Planck Institute of Biochemistry...
Items per page:
1 - 10 of 12
BioCentury | Oct 7, 2020
Tools & Techniques

Doudna and Charpentier, CRISPR pioneers behind a spate of gene editing companies, awarded Nobel Prize

...approved until more than a decade later. Lauren Martz Max Planck Institute of Biochemistry University...
BioCentury | Nov 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: October 2018

...predict chemotherapy response and survival in high-grade serous ovarian cancer (HGSOC) University of Chicago ; Max Planck Institute of Biochemistry...
BioCentury | Oct 25, 2018
Distillery Techniques

Biomarkers

...University of Chicago, Chicago, Ill. email: elengyel@uchicago.edu CONTACT: Matthias Mann, Max Planck Institute of Biochemistry, Martinsried, Germany email: mmann@biochem.mpg.de Mark Zipkin Max Planck Institute of Biochemistry University...
BioCentury | Dec 20, 2016
Distillery Techniques

Assays and screens

...M. et al. Nat. Commun. ; published online Nov. 21, 2016 doi:10.1038/ncomms13404 CONTACT: Matthias Mann, Max Planck Institute of Biochemistry...
BioCentury | Mar 13, 2014
Cover Story

Killer targets in metastasis

...cells and elicit antimetastatic effects. To do this, Penninger teamed up with scientists from the Max Planck Institute of Biochemistry...
...in the paper, including LDC1267, is licensed to Qurient Co. Ltd. from LDC and the Max Planck Institute of Biochemistry...
...the Austrian Academy of Sciences , Vienna, Austria Lead Discovery Center GmbH , Dortmund, Germany Max Planck Institute of Biochemistry...
BioCentury | Mar 13, 2014
Distillery Therapeutics

Indication: Cancer

...7(10); doi:10.1038/scibx.2014.281 Published online March 13, 2014 Patent filed by Lead Discovery Center GmbH and Max Planck Institute of Biochemistry...
BioCentury | Feb 13, 2014
Distillery Techniques

Technology: Disease models

...Heger, K. et al. PLoS Biol.; published online Jan. 14, 2014; doi:10.1371/journal.pbio.1001762 Contact: Marc Schmidt-Supprian, Max Planck Institute of Biochemistry...
BioCentury | Jan 16, 2014
Targets & Mechanisms

Putting a lid on cancer cell proteasomes

...SciBX . Baumeister is a professor at the Technical University Munich and director at the Max Planck Institute of Biochemistry...
...Mass. Howard Hughes Medical Institute , Pasadena, Calif. The Johns Hopkins University , Baltimore, Md. Max Planck Institute of Biochemistry...
BioCentury | Mar 5, 2009
Distillery Therapeutics

Indication: Hematology

...Moser, M. et al. Nat. Med.; published online Feb. 22, 2009; doi:10.1038/nm.1921 Contact: Reinhard Fässler, Max Planck Institute of Biochemistry...
BioCentury | Oct 30, 2008
Tools & Techniques

Expanding the kinase kingdom

...acute myelogenous leukemia (AML). Axel Ullrich, director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry...
...NASDAQ:GPCB), Munich, Germany Harvard Medical School , Boston, Mass. Kinaxo Biotechnologies GmbH , Martinsried, Germany Max Planck Institute of Biochemistry...
Items per page:
1 - 10 of 12